Don’t Sell This Share Before ₹585; Expert Has Advised To Take Position In This Stock
Granules India Ltd (NSE: GRANULES) Pharma Stocks To Buy: The negative effect of the low global signal affects markets in the region. In this context, many stocks appear attractive on charts of technicals.
A reputable brokerage has deemed pharmaceutical stock Granules as a technical choice. The brokerage has advised to open an investment in Granules for 2-3 days.
In the Indian market, Nifty has its monthly expiration date following the budget on Thursday. Trading began today with a huge decrease.
Nifty was trading at a decline in the range of 180 points. Sensex also started with a loss of around 500 points. Bank Nifty also showed a similar decline.
The midcap index was reported to be trading at 400 points of loss. Bank and metal stocks were in decline.
Granules: Good Profit In 2-3 Days
The brokerage company has made Granules an option for technical analysis. They have set a price target of Rs 585 for this pharmaceutical stock for the coming 2-3 days.
The stock ended at Rs 538 on the 24th of July 2024. This way the stock can rise 5-6 percent over its current price.
Granules: Stock Jumped 28 Percent In 3 Months
Granules was also in a down start on Thursday as a result of the decline in stock prices. Granules has posted an annual return of 25 percent over the past year.
In the first three months of the season, our return stands at 72 percent. However the stock has earned an increase of 29 percent in six months, and 28 percent in three months.
The stock has increased by around 10 percent in just one month. The 52-week peak of BSE’s stock is 543 while the lowest is 287.55.
The market capitalization of the company owns is more than Rs 12,942 crore.
Granules India Ltd Stock Performance
| Current Price | ₹ 550 |
| 52-wk High | ₹ 553 |
| 52-wk Low | ₹ 288 |
| 5 Days Return | 7.30% |
| 1 Month Return | 12.96% |
Key Fundamentals Parameters
| Market Cap | ₹ 13,342 Cr. |
| Stock P/E | 32.8 |
| Book Value | ₹ 133 |
| Dividend | 0.28 % |
| ROCE | 15.4 % |
| ROE | 13.4 % |
| Face Value | ₹ 1.00 |
| P/B Value | 4.21 |
| OPM | 19.0 % |
| EPS | ₹ 16.7 |
| Debt | ₹ 1,315 Cr. |
| Debt to Equity | 0.41 |
Granules India Ltd Shareholding Pattern
| Promoters Holding | |
| June 2023 | 42.02% |
| Sept 2023 | 41.97% |
| Dec 2023 | 41.97% |
| Mar 2024 | 41.96% |
| June 2024 | 38.87% |
| FII Holding | |
| June 2023 | 21.35% |
| Sept 2023 | 21.48% |
| Dec 2023 | 18.78% |
| Mar 2024 | 19.57% |
| June 2024 | 20.39% |
| DII Holding | |
| June 2023 | 6.68% |
| Sept 2023 | 7.06% |
| Dec 2023 | 10.16% |
| Mar 2024 | 10.70% |
| June 2024 | 14.11% |
| Public Holding | |
| June 2023 | 29.95% |
| Sept 2023 | 29.51% |
| Dec 2023 | 29.10% |
| Mar 2024 | 27.77% |
| June 2024 | 26.61% |
Granules India Ltd Share: Last 5 Years’ Financial Condition
Last 5 Years’ Sales:
| 2020 | ₹ 2,599 Cr |
| 2021 | ₹ 3,238 Cr |
| 2022 | ₹ 3,765 Cr |
| 2023 | ₹ 4,512 Cr |
| 2024 | ₹ 4,506 Cr |
Last 5 Years’ Net Profit:
| 2020 | ₹ 335 Cr |
| 2021 | ₹ 549 Cr |
| 2022 | ₹ 413 Cr |
| 2023 | ₹ 517 Cr |
| 2024 | ₹ 405 Cr |
Conclusion
The information and forecasts provided result from the analysis of our research team, the company’s basics and history, experience and various technical analyses.
Also, we’ve talked in depth about the shares’ prospects and growth possibilities.
If you’re new to our site and want to be updated on the latest market information, you can join us on the Telegram Group(Link below).
If you have additional questions, feel free to leave a comment below. We’ll be more than happy to address all of your questions.
Disclaimer: The information on this site is only for informational and educational purposes and shouldn’t be considered financial advice or stock recommendations.
